BTK Inhibitor Ibrutinib Speeds Remyelination via Reprogrammed Microglial Vesicles
New research shows the BTK inhibitor ibrutinib accelerates remyelination by reprogramming microglial extracellular vesicles to carry the repair-promoting microRNA miR-223.
